IP Library Granted Patent US 8,394,945
Granted Patent B2
US 8,394,945 · App. 11/683,286 · Granted Mar 12, 2013

Compositions for use in identification of bacteria

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,394,945
App. No.
11/683,286
Granted
Mar 12, 2013
Kind
B2
Abstract

The present invention provides compositions, kits and methods for rapid identification and quantification of bacteria by molecular mass and base composition analysis.

Claims (10)

1. A kit for identifying, determining one or more characteristics of, or detecting a Staphylococcus aureus bioagent comprising a first oligonucleotide primer pair comprising a forward and a reverse primer wherein said forward primer comprises the sequence of SEQ ID NO: 440 and said reverse primer comprises the sequence of SEQ ID NO: 1076 and at least one additional primer pair designed to hybridize to a Staphylococcus aureus gene encoding arcC, aroE, gmk, pta, tpi, yqi, wherein said at least one additional primer pair comprises SEQ ID NOs: 437:1232, SEQ ID NOs: 590:891, SEQ ID NOs: 474:869, SEQ ID NOs: 268:1284, SEQ ID NOs: 418:1301, SEQ ID NOs: 318:1300 or a combination thereof.

2. The kit of claim 1 further comprising at least one other additional primer pair designed to hybridize to a Staphylococcus aureus gene encoding mecA, mecR1, pvluk or a combination thereof.

3. The kit of claim 1 , wherein said forward primer of said first oligonucleotide primer pair is SEQ ID NO: 440.

4. The kit of claim 1 , wherein said reverse primer of said first oligonucleotide primer pair is SEQ ID NO: 1076.

5. The kit of claim 1 , wherein at least one of said forward primer and said reverse primer of said first oligonucleotide primer pair comprises at least one modified nucleobase.

6. The kit of claim 5 , wherein said at least one modified nucleobase is a mass modified nucleobase.

7. The kit of claim 6 , wherein said mass modified nucleobase is 5-Iodo-C.

8. The kit of claim 6 , wherein said mass modified nucleobase comprises a molecular mass modifying tag.

9. The kit of claim 5 , wherein said at least one modified nucleobase is a universal nucleobase.

10. The kit of claim 9 , wherein said universal nucleobase is inosine.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2007
From: ISIS PHARMACEUTICALS, INC.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 019691/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2007
From: SAMPATH, RANGARAJAN; HALL, THOMAS A.; ECKER, DAVID J.; BLYN, LAWRENCE
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 019315/0991 →